Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ambrx Biopharma Inc. | 62,097,896 | reported | 17 Apr 2023 | tx 6+3,597,896 |
| Immuneering Corp | 2,895,273 | reported | 01 Apr 2024 | tx 8−400,000 |
| Biomea Fusion, Inc. | 28,911 | reported | 15 Apr 2021 | tx 1−28,911 |
| OnKure Therapeutics, Inc. | 0 | reported | 15 May 2025 | tx 1−1,813,439 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2025 | SALE | OnKure Therapeutics, Inc. | 1,813,439 | 1.85 USD | |
| 01 Apr 2024 | SALE | Immuneering Corp | 280 | 2.97 USD | |
| 01 Apr 2024 | SALE | Immuneering Corp | 10 | 2.98 USD | |
| 01 Apr 2024 | SALE | Immuneering Corp | 10 | 3.01 USD | |
| 01 Apr 2024 | SALE | Immuneering Corp | 398,600 | 2.90 USD | |
| 01 Apr 2024 | SALE | Immuneering Corp | 300 | 3.07 USD | |
| 01 Apr 2024 | SALE | Immuneering Corp | 100 | 3.07 USD | |
| 01 Apr 2024 | SALE | Immuneering Corp | 600 | 3.03 USD | |
| 01 Apr 2024 | SALE | Immuneering Corp | 100 | 3.05 USD | |
| 13 Apr 2023 | PURCHASE | Ambrx Biopharma Inc. | 1,193,808 | 9.16 USD | |
| 14 Apr 2023 | PURCHASE | Ambrx Biopharma Inc. | 841,967 | 9.96 USD | |
| 17 Apr 2023 | PURCHASE | Ambrx Biopharma Inc. | 562,121 | 10.67 USD | |
| 16 Mar 2023 | PURCHASE | Ambrx Biopharma Inc. | 500,000 | 10.15 USD | |
| 14 Mar 2023 | PURCHASE | Ambrx Biopharma Inc. | 250,000 | 9.95 USD | |
| 15 Mar 2023 | PURCHASE | Ambrx Biopharma Inc. | 250,000 | 10.60 USD | |
| 15 Apr 2021 | GRANT_AWARD | Biomea Fusion, Inc. | 28,911 | 0.00 USD | deriv |